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Background: Improving lifestyle factors, including increased physical activity and exercise is associated 39 
with improved outcomes in colorectal cancer care and treatment. The purpose of this research was to 40 
assess efficacy and feasibility of a home based exercise intervention in colorectal cancer survivors 41 
(CRCS).  42 
Methods: CRCS were recruited to a 12-week multimodal exercise intervention with individualised goal 43 
setting. Physiological, psychological and biological outcomes were assessed at baseline, post-intervention 44 
(week 12) and follow up (week 24). The feasibility and acceptability of the intervention was measured 45 
by recruitment,  adherence and retention rates as well as participant satisfaction questionnaires.  46 
Results: Twenty-three stage I-IIIb CRC survivors volunteered for the research (65.7% recruitment rate). 47 
The majority were male (69.6%) with stage IIa CRC (47.82%) and 24-months post treatment. 91.6% of 48 
participants completed the intervention, of which 70% completed 219 ±108 minutes per week moderate-49 
to-vigorous intensity exercise. Results showed favourable changes to anthropometric measures with 50 
clinical improvements in cardiovascular fitness and lower body strength. These changes were in the 51 
absence of changes to blood biomarkers.  52 
Conclusion: This 12-week multimodal intervention was feasible and acceptable to CRCS and produced 53 
favourable changes to cardiovascular fitness and increases in moderate intensity PA. These findings 54 
should help inform supportive care and clinical practice in CRCS.  55 
 56 
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Introduction  61 
For several years, the link between colorectal cancer (CRC) and exercise has been widely 62 
investigated and exercise has been shown to play a role in both the primary and secondary 63 
prevention of cancer.1,2  The evidence from over 50 observational studies suggest that regular 64 
physical activity, independent of BMI, decreases the risk of CRC occurrence by approximately 65 
40%3. Epidemiological evidence also supports this preventative effect4,5. In a meta-analysis 66 
of six prospective cohort studies within colectral cancer survivors (CRCS), those who 67 
engaged in high versus low physical activity after diagnosis had a 42% lower risk of total 68 
mortality and 39% lower risk of colorectal cancer–specific mortality6. Whilst prospective 69 
and case-control studies have highlighted an inverse association between physical activity and 70 
risk of colon cancer, it is unknown whether the current recommendations of 150 minutes 71 
moderate intensity exercise7 are safe, acceptable and feasible in CRCS. There is also a paucity 72 
of research examining the behavioural and physiological effects by which exercise may 73 
exert its positive effects on clinical end points including cardiovascular fitness and blood 74 
biomarkers8. The use of such biomarkers can help determine the mechanisms underlying the 75 
benefits which exercise elicits on recurrence or progression of cancer9. This information can 76 
also provide a measurable indicator of the progression of a participant throughout an exercise 77 
intervention and enable better individualisation and precise prescription of personalised 78 
programmes to maximise supportive cancer care and rehabilitation for the individual. Whilst 79 
there can be disadvantages to home-based exercise interventions, they offer the opportunity to 80 
continue with patient rehabilitation particularly during the current COVID-19 pandemic, when 81 
access to facilities is restricted. They have several advantages over supervised facility based 82 
interventions including: a lack of reliance on costly equipment or facilities, no need for 83 
transportation to participate and the flexibility of scheduling the activity to the 84 
participant’s desired schedule10,11. Equally, home-based interventions can be more cost 85 
effective than supervised or facility based programmes11. The exercise and colorectal cancer 86 
trial’ (EXACT) study was a home based multimodal exercise intervention with the primary 87 
aims of assessing the feasibility, acceptability and biologic effects of an exercise intervention 88 
for CRCS. Our primary hypothesis was that the intervention would be safe, feasible and 89 
acceptable and that exercise would elicit improvements in cardiovascular fitness, 90 
anthropometric measures and blood biomarkers; with the overarching aim of informing a full-91 
scale RCT similar to the work of Brown and colleagues8. This study has contributed to the 92 
body of knowledge surrounding home-based exercise in CRC survivors in terms of feasibility, 93 
acceptability and biological markers. As such we feel the aim of the research has been achieved 94 





Materials and methods  98 
Study design  99 
The EXACT study was a 12 week home based multimodal exercise intervention, comprising 100 
of behaviour change and exercise in CRCS in Northern Ireland. The design of the intervention 101 
was informed by Medical Research Council (MRC) guidelines for developing complex 102 
interventions12 and a systematic review of the use of biological markers as an outcome of 103 
exercise13. The ‘Behaviour Change Wheel’ (BCW) was chosen as the framework for the 104 
development of the intervention14. The exercise intervention itself, including the activity 105 
booklet and diary concept, was adapted from previous work by our research group15, 16, 17.  106 
 107 
Participants 108 
Participants were eligible if they were Dukes A-C colorectal cancer patients at least 6 weeks 109 
post any-type of anticancer treatment; over 18 years of age; physically able to undertake the 110 
intervention without use of a walking aid15. Patients still undergoing and/or scheduled for 111 
further anti-cancer treatment, those with cognitive impairment or known co-morbidities which 112 
impact physical functioning or nutritional status and those already meeting the current 113 
recommended physical activity guidelines18 were excluded from participation. 2301 patients 114 
were screened from a patient group treated at a regional cancer centre, with 70 highlighted as 115 
being potentially eligible. Of these, 35 (50%) were referred to the researcher (see figure I). 116 
 117 
Randomisation 118 
After providing informed consent, participants were randomly allocated to usual-care control 119 
or exercise intervention (see figure II) using a computer generated random allocation. It was 120 
not possible to blind the participants or primary researcher.  121 
 122 
Intervention 123 
An educational booklet was designed which included motivational prompts, solutions to 124 
potential barriers and information on how to exercise safely and at the right intensity using the 125 
Borg scale19. Both the walking and strengthening exercises were outlined week by week, with 126 
the aim of participants eventually reaching the goal of at least 150 minutes a week of moderate 127 
intensity aerobic activity i.e. walking at least 30 minutes on at least 5 days a week, and a 128 
strengthening goal of 3 sets of 8-15 repetitions, 2-3 days a week18. An exercise diary was used 129 
to self-report the amount of exercise completed each week. The information recorded each day 130 
included: time spent walking, the number of steps completed (Yamax Digi-walker pedometer 131 
(Yamax Corp., Kumamoto, Japan), the number of sets and repetitions completed and any 132 




Group 1: The Intervention Group 135 
Following a standard fast, participants attended for baseline assessment. In addition to 136 
completing the outcome measures, participants in the intervention group received a one-to-one 137 
exercise consultation based on the BCW. During this consultation, the exercise booklet and 138 
diary were explained and their individual exercise intervention was devised. Although this was 139 
a home-based intervention, support was provided in the form of weekly researcher telephone 140 
calls to record the level of adherence (by pedometer step counts) and to seek confirmation of 141 
the completion of the strengthening component. These documented phone calls also served to 142 
address any exercise barriers and suitable exercise goals were agreed for the following week. 143 
On completion of post intervention assessments, participants completed one additional 144 
consultation aimed at promoting long term maintenance of physical activity (PA). 145 
 146 
Group 2: The Control Group 147 
Previous studies have experienced high contamination i.e. increase in activity levels within the 148 
contact control groups and thus a non-contact control group was implemented in this study15. 149 
Participants randomised to this group had the same number of visits at the same time points, as 150 
depicted in Figure II. However they did not receive the one-to-one exercise consultation and 151 
intervention information, including the booklet, diary and pedometer, until their final visit at 152 
week 24 follow-up. They did not receive weekly phone calls and continued with their usual 153 
care. 154 
 155 
Outcome measures 156 
Physiological, psychological and biological outcomes were assessed at 3 time-points; baseline 157 
(week 0), post-intervention (week 12) and follow-up (week 24). Physical activity was measured 158 
over a 7 day period (using  triaxial accelrometry Actigraph ‘GT3x’ ActiGraph, Pensacola, FL, 159 
USA). Physiological data included: anthropometric measures (height and weight, waist and hip 160 
circumference), strength and endurance of the lower extremity muscles (timed sit-to-stand 161 
(STS) test) and cardiovascular endurance (six minute walk test (6MWT). Blood biomarkers 162 
relating to metabolism (insulin like growth factor I (IGF-I), IGF binding protein 3 (IGFBP-3),  163 
glucose, total cholesterol, high density lipoprotein (HDL) cholesterol, triglycerides), 164 
inflammation (c-reactive protein (CRP), tumour necrosis factor (TNF-a), interleukin-6 (IL-6), 165 
leptin, adiponectin), immunity (full blood count) and DNA damage (COMET assay) were also 166 







Feasibility and Acceptability 172 
The feasibility of implementing this intervention in a clinical environment was assessed by 173 
monitoring; the number of clinics attended; the number of patients 174 
screened/eligible/approached; the number of patients that received and refused the study 175 
information; the number of patients who were contacted to inform the researcher whether they 176 
would be part of the study or not (reasons why recorded when given). Acceptability was 177 
measured by assessing the results of a satisfaction questionnaire given to the intervention 178 
participants post intervention (Week 12). Study adherence and completion rates of the weekly 179 
phone call were also recorded.  180 
 181 
Statistical analysis  182 
Quantitative data was analysed using SPSS version 23 (IBM Corp, USA). Descriptive statistics 183 
were used to summarise the data for inter and intra participant outcome measures over time. 184 
Independent t-tests were complete to compare the group characteristics and baseline 185 
measurement. Between group differences over time in various scores baseline, post 186 
intervention (week 12) and follow up (week 24) outcomes was analysed using a linear mixed 187 
model. A repeated measures ANOVA (group x time) was used with between group analyses 188 
performed using pairwise comparisons with least-squares (LS) means. Results are expressed 189 
as treatment effects and 95% confidence intervals. The effect size of the intervention was 190 
assessed using Cohen’s d (Cohen, 1988) analysis on the mean baseline and week 12 results 191 
from the intervention group. 192 
 193 
Results:  194 
Baseline characteristics 195 
Twenty-three stage I-IIIb CRC patients consented (65.7%) to participate in the study. The 196 
majority of participants were male (69.6%) with stage IIa CRC (47.8). The average age of 197 
participants was 62.6 (±9.1) years with an average time since treatment completion of 24 (±18) 198 
months (Table I). The majority of participants were retired (60.9%) and had received a 199 
combination of surgery and chemotherapy (60.9%).  200 
 201 
Physical activity  202 
Data from 50 out of a possible 60 sets of accelerometry data were analysed (83.3%) due to 203 
insufficient wear time. The average wear time was 15.1 hours/day for 3.96 days. Exercise 204 
prescription variables are presented in table II. There were no significant effects between 205 
groups over time for any of the PA measures. Despite this, at baseline 56% of the intervention 206 
group were achieving the guideline 150 minutes/week at baseline compared to 38% of the 207 
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control group. Over the 12 week intervention period, the average exercise volume at MVPA in 208 
the intervention and control groups were 172.5 (130.8) and 142.2 (90.3) minutes per week, 209 
respectively (figure III). On an individual basis, between baseline and week 12, seven out of 210 
eight valid datasets in the intervention group experienced an increase in MVPA whilst one 211 
demonstrated a decrease. In comparison, four of the control group increased their MVPA whilst 212 
three decreased MVPA. There was no effect for the intervention group for step counts but a 213 
large (d=-0.81) effect seen between baseline and week 12 for the control group.  214 
6MWT and sit-to-stand test  215 
Both groups improved exercise capacity scores in the 6MWT and sit-to-stand test however 216 
these were not significant. Both groups experienced moderate improvements in the sit-to-stand 217 
test at week 12. A large improvement however was seen in the control group for the 6MWT 218 
(d=-0.98), whilst a moderate effect was reported in the intervention group (d=0.77) (table III).  219 
 220 
Biological outcome measures 221 
There were no significant changes from baseline to post intervention in any of the blood 222 
biomarkers (supplementary table II). A moderate improvement was seen for total cholesterol 223 
in the intervention group (d=0.56) compared to no effect in the control (d=0.02) at week 12. 224 
This was accompanied by a large effect for LDL cholesterol in the intervention group (d=0.87) 225 
vs a small change in the control group (d=0.37). Control group HDL cholesterol increased more 226 
favourably vs intervention (d=0.62 vs d=0.19 respectively). Blood glucose concentration 227 
(BGC) increased in the control group at each time-point (6.2+1.4, 6.28+2.0, 7.2+2.5) whereas 228 
it decreased in intervention (6.6+2.5 vs. 6.5+2.7) before returning to 7.0+1.3 mmol.l-1 by 229 
follow up.  230 
 231 
DNA damage  232 
There were no significant changes in DNA damage between any time-point (see supplementary 233 
table I). There was a moderate effect in the intervention compared to a small effect in the 234 
control group at week 12 (d=0.75 and d=0.35 respectively). The intervention group values 235 
increased in comparison to the control group (229.51±56.83µm to 287.2±93.3µm versus 236 
202.4±107.5µm to 233.0±60.5µm) and had a greater decrease at week 24 (287.2±93.3µm to 237 




Anthropometric measures  240 
Small effect sizes were seen for weight (d=0.22), BMI (d=0.24) and waist circumference 241 
(d=0.34) in the intervention group at week 12 with all three measures decreasing 242 
(supplementary table I). Hip and waist circumference increased in the control group over time  243 
(P0.05). 244 
 245 
Feasibility and acceptability 246 
Taking into account sessions that were not attended, blood samples were not taken or 247 
incomplete for a total of 7 occasions (11.1%). 97.7% of the 12-weekly phone calls were 248 
complete with 90.9% of participants recording daily step counts. The average length of the 249 
weekly phone calls was 8 minutes 21 seconds per patient. 90.9% of participants recorded their 250 
daily activity and step count totals for all 7 days of the 12-week intervention. The results of the 251 
satisfaction questionnaire were all positive. When participants were asked; ‘Looking back, was 252 
there anything that you did not like about the programme?’ 100% of participants provided 253 
positive comments such as; “No, the programme was educational and easy to follow with the 254 
booklet provided. *The Individual delivering the research* was very supportive throughout the 255 
programme” and “No- the programme provided an incentive to exercise more - much needed.” 256 
When asked; ‘Can you suggest anyway the programme could consume been made better for 257 
you, or for other people taking part in future programmes?’ The majority of the participants 258 
answered ‘no’ with additional comments such as; “No, it was professionally put together and 259 










The findings from our study suggest that a 12 week home-based multimodal exercise 270 
intervention is both feasible and acceptable to colorectal patients who have completed cancer 271 
treatment. Exercise was well tolerated and enjoyable, with both the intervention and control 272 
group able to complete exercise at moderate-vigorous intensity aligned with current PA 273 
guidelines for cancer survivors15. Using the National Institute for Health Research (NIHR) 274 
description of  feasibility, this intervention can be considered feasible for a fully powered RCT. 275 
NIHR states that prior to an RCT, studies completed should aim to answer “can this study be 276 
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done?”20.Furthermore, the criterions that need to be recorded in order to answer this question 277 
include; the willingness of participants to be randomised; the willingness of the clinicians to 278 
recruit participants; the number of eligible participants; the follow-up rates, response rates to 279 
questionnaires, adherence/compliance rates; and the time needed to collect and analyse the 280 
data20. Participants in this study were willing to be randomized with limited drop-out (8.7%) 281 
and high recruitment (65.7%) rates. Willingness of the clinicians to recruit participants was 282 
also high; with all nine clinicians (4 oncologists; 5 surgeons) dealing with CRC patients in the 283 
regional cancer centre voluntary agreed to recruit. Park and colleagues21 have previously 284 
demonstrated that the majority of clinicians agree that exercise is both beneficial (72.8%) and 285 
important (69.6%) for patients however, barriers such as lack of time, unclear exercise 286 
guidelines for cancer patients and concerns about safety were the most commonly reported 287 
reasons for clinicians to not discuss exercise21. This also has implications for informing future 288 
RCT design. The recruitment rate for EXACT was 65.7% (out of a possible 70 participants 289 
identified over a 10 month period). This is very favourable compared to four other similar 290 
studies which had rates less than 35%22, 23, 24, 3.6 The reason for this high recruitment rate may 291 
be attributable to the active role of the researcher at the oncology and surgery clinics, meeting 292 
the participant face-to-face from outset of study introduction. Researcher support throughout 293 
the study in terms of weekly telephone contact and the study resources (based on previous work 294 
by our research group15, 16, 17) may also have contributed to the high retention rates for EXACT, 295 
with 82.6% of the participants completing all three assessment sessions over the six-month 296 
study duration.  297 
 298 
In our study, 38% of the control group and 56% of the intervention group were already 299 
achieving the recommended level of at least 150 min/week of MVPA at baseline18. This is 300 
encouraging given the objective measurement of PA via accelerometry which is somewhat 301 
limited in cancer survivors. Recent work published by Vallance and colleagues36 in a sample 302 
of 181 CRCS revealed that only 15.7% of those sampled were achieving the guidelines for 303 
MVPA, so at the outset more than double of the EXACT participants were already achieving 304 
the recommended level of PA for health. Our results are similar to the work of Brown and 305 
colleagues8 who examined the dose-response effects of 150 and 300 minutes of aerobic exercise 306 
in a home based setting for 6 months. They concluded that higher volumes of moderate-307 
intensity aerobic exercise (up to 300 minutes/week) are feasible, safe, and elicit favourable 308 
changes in some prognostic blood biomarkers in CRCS. For EXACT, the favourable trends 309 
observed for cardiovascular fitness and anthropometric measures were largely in the absence 310 
of changes to the blood biomarkers assessed. The biological pathways by which exercise may 311 
influence or reduce the risk of colorectal cancer recurrence and premature mortality have not 312 
yet been elucidated8. The proposed mechamisms are varied, but include changes in 313 
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inflammation, hormones, DNA repair and immune function25. As such, and following a 314 
systematic review of the literature13 the EXACT study sampled a range of investigative 315 
biomarkers relating to metabolism, inflammation, immunity and DNA damage in CRC. Whilst 316 
our results largely showed no significant changes, it remains undetermined whether these 317 
biomarkers would also remain unchanged at higher exercise doses as employed by Brown et 318 
al8 or within a large scale RCT.  Despite the positive trends in relation to PA in this study, none 319 
of the measures displayed significance over time. In light of the work by Brown and colleagues 320 
previously discussed8, it is possible that exercise tolerance for CRCS might be greater than 321 
initially thought. Brown et al demonstrated that a high dose of exercise (300 minutes per week) 322 
was tolerable and crucially, produced positive changes to blood biomarkers8. We suggest that 323 
the results of EXACT further support the argument that PA research in CRCS requires 324 
additional resesarch at varying exercise doses and intensities; along with in-depth investigation 325 
of blood biomarkers to clearly elucidate the biologic pathways involved. As regular exercise 326 
up-regulates mytokine secretion25 and anti-inflammatory processes resulting in the 327 
transcription of nuclear factor-B (NF-B) involved in inflammation, immunity, cell 328 
proliferation and differentiation a wide range of biomarkers requires investigation.  329 
 330 
DNA damage 331 
Recent work by Vodicka et al26 has clearly documented the potential role of the comet assay as 332 
a sensitive and cost-effective technique in investigating DNA damage and repair in cancer 333 
patients. Similar to Browns paper8 which demonstrated that exercise favourably alters 334 
oxidative DNA damage, our findings also help to contribute to the knowledge base in colorectal 335 
cancer. Given that the percentage of DNA in the tail is directly proportional to the amount of 336 
damaged DNA present27; intervention values for EXACT were higher (but not significantly) 337 
than the control group at baseline. At week 12 this figure increased in the intervention group 338 
but decreased in the control; with control group week 24 values remaining stable whilst the 339 
intervention values dropped by approximately 10%. To the author’s knowledge, no other study 340 
has used the comet assay to measure DNA damage within a colorectal cancer PA intervention; 341 
only in a longitudinal observational study28 and in a drug trial in vivo and in vitro29. Therefore, 342 
baseline data must be compared with non-cancer population studies. Studies that analysed the 343 
comet assay on lymphocytes reported findings for % tail length as 5-8% in trained athletes30, 31 344 
and 30-40% in untrained and/or sedentary participants32, 33. The baseline levels for participants 345 
in the ‘EXACT’ study were 30% in the intervention and 24% in the control. Cancer is 346 
essentially a disease of DNA and many of the anti-cancer treatments received by participants 347 
induce further DNA damage, some of which is later repaired. As participants were on average 348 
24 months post treatment, it is conceivable that baseline levels are within range of the general 349 
population. Between baseline and week 24, control group levels remained relatively stable. For 350 
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the intervention group, levels increased by 2.8% at week 12 but decreased by over 10% at week 351 
24. None of these changes were significant however so no definitive conclusions can be drawn. 352 
Exercise does induce DNA damage34 but long term exercise can up-regulate the DNA-repair 353 
system35 This may help explain the trend seen in the intervention group however this would 354 
require additional research over a longer experimental exercise period and at varying 355 
intensities. Certain limitations existed within the present study, including limited capacity (one 356 
researcher) to recruit at one (of two) regional cancer centres. Additional resource would have 357 
assisted in attending the other clinic and analysing additional blood biomarkers but 358 
unfortunately this was outside the scope of the current doctoral project.  359 
 360 
Conclusion: 361 
Exercise and physical activity in cancer rehabilitation is an expanding area of research with 362 
data from cohort studies suggesting the potential benefits of exercise. This 12-week multimodal 363 
intervention and follow up was feasible and acceptable to colorectal cancer survivors and 364 
produced favourable changes to cardiovascular fitness and increases in moderate intensity 365 
physical activity. These were largely in the absence of changes to blood biomarkers. These 366 
results can be used to guide physical therapy recommendations for rehabilitation of colorectal 367 
cancer patients, which in turn may benefit patient outcomes post surgery and treatment. Further 368 
research is required to enable clinicians to fully understand the biologic pathways by which 369 
exercise may ameliorate colorectal cancer progression and outcomes. There is also a need to 370 
establish the dose, duration and intensity of exercise required in a clinical or home based setting 371 
to alter metabolic, inflammatory, immune and DNA damage biomarkers. In conclusion, the 372 
results of the EXACT study can assist in informing clinical recommendations surrounding 373 
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Table I. Participant characteristics 
 Control Group (n=11) Exercise Group (n=12) 
Demographics:   
Age in years 62.6 (9.1) 63.6 (9.5) 
Male% 54.5% (n=6) 83.3% (n=10) 
Female% 45.5% (n=5) 16.7% (n=2) 
Marital Status:   
Single 9.1% (n=1) 8.3% (n=1) 
Married 72.7% (n=8) 75.0% (n=9) 
Living with partner 18.2% (n=2) 8.3% (n=1) 
Widowed 0.0% (n=0) 8.3% (n=1) 
Occupation:   
Professional 45.5% (n=5) 41.6% (n=5) 
Managerial 0.0% (n=0) 25.0% (n=3) 
Clerical 9.0% (n=1) 16.7% (n=2) 
Manual 45.5% (n=5) 16.7% (n=2) 
Work Status:   
Full-time 0.0% (n=0) 25.0% (n=3) 
Part-time 36.4% (n=4) 8.3% (n=1) 
Long-term sick leave 9.1% (n=1) 0.0% (n=0) 
Retired 54.5% (n=6) 66.7% (n=8) 
Cancer Type:   
Colon 81.8% (n=9) 66.7% (n=8) 
Rectal 18.2% (n=2) 33.3% (n=4) 
Stage:   
1a 0% (n=0) 8.3% (n=1) 
2a/2b 54.5% (n= 6) 58.3% (n=7) 
3a/3b/3c 45.5% (n= 5) 33.3% (n=4) 
Treatment received:   
Surgery only 18.2% (n=1) 33.3% (n=4) 
Surgery & chemotherapy 72.7% (n=8) 50.0% (n=6) 




Table II: Exercise prescription variables at baseline, post intervention and follow up.  
 
* All values presented are means+SD . Step count expressed as total steps/week, light, 
moderate, moderate to vigorous and vigorous  physical activity (PA) expressed in 
minutes/week.  
 
Table III: Exercise capacity variables at baseline, post intervention and follow up. 
 * All values presented are means+SD. 6MWT expressed in metres and sit-to-stand test 
(repetitions).  
 
Characteristic* Baseline (week 0) Post intervention (week 12) Follow up (week 24) 
 Intervention Control  Intervention Control Intervention Control 
Step count  32582 (24640) 24261 (7497) 36184 (14638) 35390 (18014) 25106(16668) 13434 (15157) 
Light PA 924.9 (505.8) 806.4 (340.7) 807.8 (245.5) 1020.9 (309.0) 792.9 (326.6) 817.9 (388.9) 
Moderate PA  172.5 (130.8) 141.2 (90.3) 212.1 (107.5) 190.9 (140.0) 173.3 (86.2) 129.1 (93.0) 
MVPA  183.2 (132.2) 146.8 (98.2) 218.7 (108.1) 205.5 (161.0) 177.6 (89.1) 130.8 (93.3) 





56  38 59 57 63 50 
Characteristic* Baseline (week 0) Post intervention (week 12) Follow up (week 24) 
 Intervention Control  Intervention Control Intervention Control 
6MWT  535(63) 506(51) 592(83) 556(51) 610(96) 576(54) 
Sit-to-stand  15(6) 12(2) 18(7) 14(4) 18(5) 16(4) 
